Your search returned 22 results.

Results
	1.	[111In-DTPA-D-Phe1]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: a pilot study. [electronic resource] by Kälkner, K M Nilsson, S Westlin, J E Producer: 19980513 In: Anticancer research vol. 18 Availability: No items available. Save to lists Add to cart (remove)
	2.	89Strontium in the management of painful sceletal metastases. [electronic resource] by Kälkner, K M Westlin, J E Strang, P Producer: 20000531 In: Anticancer research vol. 20 Availability: No items available. Save to lists Add to cart (remove)
	3.	Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma. [electronic resource] by Edgren, M Lennernäs, B Larsson, A Kälkner, K M Producer: 20010726 In: Anticancer research vol. 21 Availability: No items available. Save to lists Add to cart (remove)
	4.	A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients. [electronic resource] by Janson, E T Gobl, A Kälkner, K M Oberg, K Producer: 19960730 In: Cancer research vol. 56 Availability: No items available. Save to lists Add to cart (remove)
	5.	Pain figures are unsuitable for determination of palliative radiotherapy portals in patients with hormone refractory prostatic cancer. [electronic resource] by Kälkner, K M Westlin, J E Nilsson, S Strang, P Producer: 19980731 In: Anticancer research vol. 18 Availability: No items available. Save to lists Add to cart (remove)
	6.	Comparison between transversal SPECT, 3-dimensional rendering and 3-dimensional rendering plus clipping in the diagnosis of somatostatin receptor distribution in malignancies using 111In-DTPA-D-Phe1-octreotide scintigraphy. [electronic resource] by Kälkner, K M Nilsson, S Ylä-Jääski, J Westlin, J E Producer: 20000629 In: Cancer biotherapy & radiopharmaceuticals vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Clinical significance of circulating CD44 in non-Hodgkin's lymphoma. [electronic resource] by Ristamäki, R Joensuu, H Hagberg, H Kalkner, K M Jalkanen, S Producer: 19980702 In: International journal of cancer vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas. [electronic resource] by Christiansen, I Sundström, C Kälkner, K M Bring, J Tötterman, T H Producer: 19990419 In: European journal of haematology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas. [electronic resource] by Christiansen, I Sundström, C Kälkner, K M Bring, J Tötterman, T H Producer: 19990104 In: European journal of haematology vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	[111In-DPTA-D-Phe1]-octreotide scintigraphy in the management of patients with advanced renal cell carcinoma. [electronic resource] by Edgren, M Westlin, J E Kälkner, K M Sundin, A Nilsson, S Producer: 20000724 In: Cancer biotherapy & radiopharmaceuticals vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers. [electronic resource] by Christiansen, I Gidlof, C Kälkner K, M Hagberg, H Bennmarker, H Tötterman, T Producer: 19960610 In: British journal of haematology vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors. [electronic resource] by Janson, E T Kälkner, K M Eriksson, B Westlin, J E Oberg, K Producer: 20000411 In: Nuclear medicine and biology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival. [electronic resource] by Christiansen, I Enblad, G Kälkner, K M Gidlöf, C Glimelius, B Tötterman, T H Producer: 19960208 In: Leukemia & lymphoma vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effects. [electronic resource] by Edgren, M Westlin, J E Letocha, H Nordgren, H Kälkner, K M Nilsson, S Producer: 19960903 In: Acta oncologica (Stockholm, Sweden) vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon. [electronic resource] by Kälkner, K M Rönnblom, L Karlsson Parra, A K Bengtsson, M Olsson, Y Oberg, K Producer: 19980824 In: QJM : monthly journal of the Association of Physicians vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers. [electronic resource] by Kälkner, K M Janson, E T Nilsson, S Carlsson, S Oberg, K Westlin, J E Producer: 19960111 In: Cancer research vol. 55 Availability: No items available. Save to lists Add to cart (remove)
	17.	Infradiaphragmatic Hodgkin's disease: the Swedish National Care Programme experience. The Swedish Lymphoma Study Group. [electronic resource] by Kälkner, K M Enblad, G Gustavsson, A Starkhammar, H Branehög, I Lenner, P Glimelius, B Producer: 19970904 In: European journal of haematology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	PET with hydroxytryptophan as tracer in hormone-refractory prostatic adenocarcinoma: evaluation of decarboxylation in vivo. [electronic resource] by Kälkner, K M Nilsson, S Bergström, M Lindner, K J Westerberg, G Långström, B Westlin, J E Producer: 19980305 In: In vivo (Athens, Greece) vol. 11 Availability: No items available. Save to lists Add to cart (remove)
	19.	Positron emission tomography (PET) with 11C-5-hydroxytryptophan (5-HTP) in patients with metastatic hormone-refractory prostatic adenocarcinoma. [electronic resource] by Kälkner, K M Ginman, C Nilsson, S Bergström, M Antoni, G Ahlström, H Långström, B Westlin, J E Producer: 19970918 In: Nuclear medicine and biology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy. [electronic resource] by Nilsson, S Reubi, J C Kalkner, K M Laissue, J A Horisberger, U Olerud, C Westlin, J E Producer: 19960111 In: Cancer research vol. 55 Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 22 results.